東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Fatty liver." ]

切換: 標籤 | MARC模式 | ISBD

Essentials of non-alcoholic fatty li...

Trifan, Anca.

FindBook

Google Book

Amazon

博客來

Essentials of non-alcoholic fatty liver disease = complications and extrahepatic manifestations /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Essentials of non-alcoholic fatty liver disease/ edited by Anca Trifan, Carol Stanciu, Cristina Muzica.
其他題名:	complications and extrahepatic manifestations /
其他作者:	Trifan, Anca.
出版者:	Cham :Springer International Publishing : : 2023.,
面頁冊數:	xv, 267 p. :ill., digital ;24 cm.
內容註:	Chapter 1: The nomenclature and definition of nonalcoholic fatty liver disease -- Chapter 2: Nonalcoholic fatty liver disease versus metabolic associated fatty liver disease -- Chapter 3: Natural history of nonalcoholic fatty liver disease -- Chapter 4: Hepatocellular carcinoma in nonalcoholic fatty liver disease -- Chapter 5: Genetics and epigenetics in nonalcoholic fatty liver disease -- Chapter 6: The place of transabdominal liver biopsy in nonalcoholic fatty liver disease -- Chapter 7: Alternative methods for liver biopsy - endoscopic ultrasound-guided and transjugular liver biopsy- endoscopic ultrasound-guided and transjugular liver biopsy -- Chapter 8: Morphopathology of nonalcoholic fatty liver disease -- Chapter 9: 2D shear wave elastography performance in the diagnosis of nonalcoholic fatty liver disease -- Chapter 10: Vibration controlled transient elastography and controlled attenuation parameter for staging nonalcoholic fatty liver disease -- Chapter 11: The value of serologic markers/scores in the assessment of nonalcoholic fatty liver disease -- Chapter 12: Nonalcoholic fatty liver disease within other causes of chronic liver diseases -- Chapter 13: Pathophisiology and risk stratification in cardiovascular diseases and NAFLD -- Chapter 14: Type 2 diabetes mellitus and insulin resistance in nonalcoholic fatty liver disease -- Chapter 15: Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease -- Chapter 16: Endocrinopathies in nonalcoholic fatty liver disease -- Chapter 17: Nonalcoholic Fatty liver disease and extraheoatic malignancies -- Chapter 18: Psychological burden of NAFLD and psychiatric disorders as extrahepatic manifestations -- Chapter 19: Obstructive sleep apnea syndrome and nonalcoholic fatty liver disease -- Chapter 20: Nonalcoholic fatty liver disease and psoriasis -- Chapter 21: Current management and pipeline treatment approaches in NAFLD - summary of ongoing RCTs and future directions -- Chapter 22: Practical clinical cases in nonalcoholic fatty liver disease.
Contained By:	Springer Nature eBook
標題:	Fatty liver. -
電子資源:	https://doi.org/10.1007/978-3-031-33548-8
ISBN:	9783031335488

Essentials of non-alcoholic fatty liver disease = complications and extrahepatic manifestations /
Essentials of non-alcoholic fatty liver diseasecomplications and extrahepatic manifestations /[electronic resource] :edited by Anca Trifan, Carol Stanciu, Cristina Muzica. - Cham :Springer International Publishing :2023. - xv, 267 p. :ill., digital ;24 cm.

Chapter 1: The nomenclature and definition of nonalcoholic fatty liver disease -- Chapter 2: Nonalcoholic fatty liver disease versus metabolic associated fatty liver disease -- Chapter 3: Natural history of nonalcoholic fatty liver disease -- Chapter 4: Hepatocellular carcinoma in nonalcoholic fatty liver disease -- Chapter 5: Genetics and epigenetics in nonalcoholic fatty liver disease -- Chapter 6: The place of transabdominal liver biopsy in nonalcoholic fatty liver disease -- Chapter 7: Alternative methods for liver biopsy - endoscopic ultrasound-guided and transjugular liver biopsy- endoscopic ultrasound-guided and transjugular liver biopsy -- Chapter 8: Morphopathology of nonalcoholic fatty liver disease -- Chapter 9: 2D shear wave elastography performance in the diagnosis of nonalcoholic fatty liver disease -- Chapter 10: Vibration controlled transient elastography and controlled attenuation parameter for staging nonalcoholic fatty liver disease -- Chapter 11: The value of serologic markers/scores in the assessment of nonalcoholic fatty liver disease -- Chapter 12: Nonalcoholic fatty liver disease within other causes of chronic liver diseases -- Chapter 13: Pathophisiology and risk stratification in cardiovascular diseases and NAFLD -- Chapter 14: Type 2 diabetes mellitus and insulin resistance in nonalcoholic fatty liver disease -- Chapter 15: Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease -- Chapter 16: Endocrinopathies in nonalcoholic fatty liver disease -- Chapter 17: Nonalcoholic Fatty liver disease and extraheoatic malignancies -- Chapter 18: Psychological burden of NAFLD and psychiatric disorders as extrahepatic manifestations -- Chapter 19: Obstructive sleep apnea syndrome and nonalcoholic fatty liver disease -- Chapter 20: Nonalcoholic fatty liver disease and psoriasis -- Chapter 21: Current management and pipeline treatment approaches in NAFLD - summary of ongoing RCTs and future directions -- Chapter 22: Practical clinical cases in nonalcoholic fatty liver disease.

The book is a compact yet comprehensive practical resource which highlights all must-know information on non-alcoholic fatty liver disease (NAFLD) Covering the major issues dominating the field, this book offers a broad vision on NAFLD using key data for a deep and thorough understanding of the latest diagnostic methods, treatment options, potential complications, and disease management strategies to improve patient outcomes. The volume bridges the trans-disciplinary divide between hepatologists, cardiologists, nephrologists, psychiatrists, oncologists and dermatologists in order to cover in a single volume the complex management of NAFLD. It operates under a modern definition of NAFLD which acknowledges the range of presentations related to extrahepatic complications that hepatologists see in daily practice, while delving also into unanswered questions and future directions regarding treatment options. Offering practical, clinical guidance in addition to capturing the new promising therapeutic approaches in the pipeline, this book is an essential reference for clinicians, researchers and students.

ISBN: 9783031335488

Standard No.: 10.1007/978-3-031-33548-8doiSubjects--Topical Terms:

2181360
Fatty liver.

LC Class. No.: RC848.F3

Dewey Class. No.: 616.362

Essentials of non-alcoholic fatty liver disease = complications and extrahepatic manifestations /
LDR:04176nmm a2200325 a 4500 001 2334099
003 DE-He213
005 20230811163515.0
006 m d
007 cr nn 008maaau
008 240402s2023 sz s 0 eng d
020 $a 9783031335488 $q (electronic bk.)
020 $a 9783031335471 $q (paper)
024 7 $a 10.1007/978-3-031-33548-8 $2 doi
035 $a 978-3-031-33548-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC848.F3
072 7 $a MNG $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MNG $2 thema
082 0 4 $a 616.362 $2 23
090 $a RC848.F3 $b E78 2023
245 0 0 $a Essentials of non-alcoholic fatty liver disease $h [electronic resource] : $b complications and extrahepatic manifestations / $c edited by Anca Trifan, Carol Stanciu, Cristina Muzica.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xv, 267 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1: The nomenclature and definition of nonalcoholic fatty liver disease -- Chapter 2: Nonalcoholic fatty liver disease versus metabolic associated fatty liver disease -- Chapter 3: Natural history of nonalcoholic fatty liver disease -- Chapter 4: Hepatocellular carcinoma in nonalcoholic fatty liver disease -- Chapter 5: Genetics and epigenetics in nonalcoholic fatty liver disease -- Chapter 6: The place of transabdominal liver biopsy in nonalcoholic fatty liver disease -- Chapter 7: Alternative methods for liver biopsy - endoscopic ultrasound-guided and transjugular liver biopsy- endoscopic ultrasound-guided and transjugular liver biopsy -- Chapter 8: Morphopathology of nonalcoholic fatty liver disease -- Chapter 9: 2D shear wave elastography performance in the diagnosis of nonalcoholic fatty liver disease -- Chapter 10: Vibration controlled transient elastography and controlled attenuation parameter for staging nonalcoholic fatty liver disease -- Chapter 11: The value of serologic markers/scores in the assessment of nonalcoholic fatty liver disease -- Chapter 12: Nonalcoholic fatty liver disease within other causes of chronic liver diseases -- Chapter 13: Pathophisiology and risk stratification in cardiovascular diseases and NAFLD -- Chapter 14: Type 2 diabetes mellitus and insulin resistance in nonalcoholic fatty liver disease -- Chapter 15: Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease -- Chapter 16: Endocrinopathies in nonalcoholic fatty liver disease -- Chapter 17: Nonalcoholic Fatty liver disease and extraheoatic malignancies -- Chapter 18: Psychological burden of NAFLD and psychiatric disorders as extrahepatic manifestations -- Chapter 19: Obstructive sleep apnea syndrome and nonalcoholic fatty liver disease -- Chapter 20: Nonalcoholic fatty liver disease and psoriasis -- Chapter 21: Current management and pipeline treatment approaches in NAFLD - summary of ongoing RCTs and future directions -- Chapter 22: Practical clinical cases in nonalcoholic fatty liver disease.
520 $a The book is a compact yet comprehensive practical resource which highlights all must-know information on non-alcoholic fatty liver disease (NAFLD) Covering the major issues dominating the field, this book offers a broad vision on NAFLD using key data for a deep and thorough understanding of the latest diagnostic methods, treatment options, potential complications, and disease management strategies to improve patient outcomes. The volume bridges the trans-disciplinary divide between hepatologists, cardiologists, nephrologists, psychiatrists, oncologists and dermatologists in order to cover in a single volume the complex management of NAFLD. It operates under a modern definition of NAFLD which acknowledges the range of presentations related to extrahepatic complications that hepatologists see in daily practice, while delving also into unanswered questions and future directions regarding treatment options. Offering practical, clinical guidance in addition to capturing the new promising therapeutic approaches in the pipeline, this book is an essential reference for clinicians, researchers and students.
650 0 $a Fatty liver. $3 2181360
650 1 4 $a Gastroenterology. $3 828956
650 2 4 $a Internal Medicine. $3 858559
650 2 4 $a Cardiology. $3 861477
650 2 4 $a Nephrology. $3 894870
650 2 4 $a Oncology. $3 751006
650 2 4 $a Dermatology. $3 829009
700 1 $a Trifan, Anca. $3 3665411
700 1 $a Stanciu, Carol. $3 3665412
700 1 $a Muzica, Cristina. $3 3665413
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-33548-8
950 $a Medicine (SpringerNature-11650)